What is the Impact Factor of Leukemia?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Leukemia is 8.80, ranking in quartile Q1 of Web of Science (SCIE).

Is Leukemia indexed in Web of Science or Scopus?

Yes, Leukemia is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 3.675 (Q1) and an H-index of 235.

Who publishes Leukemia and what is the Article Processing Charge (APC)?

Leukemia is published by Springer Nature. The estimated Article Processing Charge (APC) is approximately $4,225 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Leukemia?

The official ISO-4 abbreviation of Leukemia is "LEUKEMIA" with common acronym "leu". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #506Top JournalHybrid

Leukemia

Acronym:leu

•

Abbreviation (ISO):LEUKEMIA

•

Identifier (ISSN):0887-6924(Print)/1476-5551(Online)

•

Publisher:Springer Nature

Official Website Submission Portal Compare

Clarivate IF (2026)

8.8↓ -4.6

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Leukemia

WoS Q1

Annual Impact Factor Metric

Current (2026):8.8

Scopus SJR & RankScopus Q1

3.675

#506

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

235

235 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate3.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

231articles/year

65.87% Gold OA•87.98% Original Research

Aims & Scope

Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more. We publish a range of content types including original research articles, reviews, letters, correspondence and comments that elaborate on significant advances in the field and cover topical issues.

Topics Covered (Recognized by AI)

Medicine98.2%Biology97.3%Genetics91.4%Internal medicine91%Immunology87%Chemistry71.3%Biochemistry69%Cancer research61.4%Gene51.9%Leukemia47.9%Pathology47.4%Cell biology37.5%Surgery25.7%Oncology24.3%Molecular biology23.5%Stem cell23%Myeloid leukemia22.5%Bone marrow22.1%

Primary Research Areas

Medicine Hematology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

HEMATOLOGY

Rank10/103

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank39/333

IndexSCIE

JCISCIE2026

HEMATOLOGY

Rank9/103

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank30/333

IndexSCIE

Category	Index	Rank	Quartile
HEMATOLOGY	JCRSCIE	10/103	Q1
ONCOLOGY	JCRSCIE	39/333	Q1
HEMATOLOGY	JCISCIE	9/103	Q1
ONCOLOGY	JCISCIE	30/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF8.8

Articles / Year291

Total Citations185

2025

IF13.4

Articles / Year340

Total Citations2,095

2024

IF12.8

Articles / Year369

Total Citations4,541

2023

IF11.4

Articles / Year317

Total Citations5,643

2022

IF12.883

Articles / Year330

Total Citations17,174

Year	Impact Factor	Articles / Year	Total Citations
2026	8.8	291	185
2025	13.4	340	2,095
2024	12.8	369	4,541
2023	11.4	317	5,643
2022	12.883	330	17,174
2021	11.528	373	14,427
2020	8.665	415	21,631
2019	9.944	360	19,629
2018	10.023	329	21,660
2017	—	361	24,136
2016	—	393	23,005
2015	—	363	24,714

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #506Scopus Q1SCImago Profile

Scopus Coverage:1987-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

3.675

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

6.24

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,225 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations7,497

3-Year Documents978

Citable Documents833

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)4

Citations in government and international policy documents

Female Author Rate43.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Anesthesiology and Pain MedicineQ1

Cancer ResearchQ1

HematologyQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

2区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Leukemia (acronym: leu, abbr: LEUKEMIA, ISSN: 0887-6924) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in England since 1997. The periodical holds a Journal Impact Factor (JIF) of 8.80, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.675 (Q1), an H-index of 235.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 231 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,225 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.